Northern California Foot and Ankle Center initiates diabetic foot ulcer trial
The Matrix trial is a randomized, double-blind, placebo-controlled, comparator arm (standard of care) safety and efficacy study to evaluate Excellarate (GAM501) that is topically administered once or twice
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.